Utility value of the S3-score in metastatic and non-metastatic clear cell renal cell carcinoma for a molecular prediction of clinical outcome

2018 ◽  
Vol 17 (2) ◽  
pp. e117
Author(s):  
F. Büttner ◽  
S. Winter ◽  
S. Rausch ◽  
J. Hennenlotter ◽  
S. Kruck ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Clinical Outcome ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Clear Cell ◽  
Utility Value ◽  
Cell Renal Cell Carcinoma

PARK2andPACRGare commonly downregulated in clear-cell renal cell carcinoma and are associated with aggressive disease and poor clinical outcome

2012 ◽  
Vol 52 (3) ◽  
pp. 265-273 ◽  
Author(s):  
Marieta I. Toma ◽  
Daniela Wuttig ◽  
Sandy Kaiser ◽  
Alexander Herr ◽  
Thomas Weber ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Clinical Outcome ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Clear Cell ◽  
Poor Clinical Outcome ◽  
Cell Renal Cell Carcinoma ◽  
Aggressive Disease

CD147, The Ancillary protein of MCT4, as marker for prognosis and clinical outcome in primary clear cell renal cell Carcinoma and Metastasis

2015 ◽  
Vol 37 (8) ◽  
pp. e75-e76 ◽  
Author(s):  
P. Fisel ◽  
V. Stühler ◽  
S. Winter ◽  
S. Rausch ◽  
J. Hennenlotter ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Clinical Outcome ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Clear Cell ◽  
Cell Renal Cell Carcinoma

scholarly journals Capn4 mRNA level is correlated with tumour progression and clinical outcome in clear cell renal cell carcinoma

2014 ◽  
Vol 42 (2) ◽  
pp. 282-291 ◽  
Author(s):  
Qianfeng Zhuang ◽  
Xi Qian ◽  
Yunjie Cao ◽  
Min Fan ◽  
Xianlin Xu ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Clinical Outcome ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Clear Cell ◽  
Tumour Progression ◽  
Mrna Level ◽  
Cell Renal Cell Carcinoma
Sign in / Sign up

Export Citation Format

Share Document